Germline variants in genes such as CEBPA, DDX41, RUNX1, ETV6 and GATA2 should be considered in patients when mutations in these genes are seen in tumor sequencing tests, especially when the mutations are biallelic or consistent with their presence in the germline (264). This evidence concerns the gene DDX41 and neoplasm.